Cephalon Sues Apotex To Block Generic Nuvigil
Cephalon Inc. has hit Apotex Corp. with a lawsuit that accuses the rival drug manufacturer of infringing a pair of patents for Nuvigil, in an attempt to block a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article